Statements (40)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:pharmacy
|
gptkbp:abbreviation |
Ph. Eur.
|
gptkbp:appliesTo |
gptkb:European_Union
Council of Europe member states |
gptkbp:contains |
monographs
general chapters general notices |
gptkbp:countryOfOrigin |
gptkb:France
|
gptkbp:covers |
veterinary medicines
medicinal products biologicals active substances dosage forms excipients herbal drugs |
gptkbp:edition |
11th edition (2023)
|
gptkbp:governingBody |
European Pharmacopoeia Commission
|
gptkbp:headquartersLocation |
gptkb:Strasbourg
|
https://www.w3.org/2000/01/rdf-schema#label |
European Pharmacopoeia
|
gptkbp:language |
gptkb:French
English |
gptkbp:legalStatus |
legally binding in signatory states
|
gptkbp:publishedBy |
gptkb:Council_of_Europe
European Directorate for the Quality of Medicines & HealthCare |
gptkbp:purpose |
standardization of medicines
|
gptkbp:relatedTo |
gptkb:United_States_Pharmacopeia
gptkb:World_Health_Organization gptkb:British_Pharmacopoeia |
gptkbp:releaseDate |
1969
|
gptkbp:scope |
quality standards for medicines and substances
|
gptkbp:updated |
periodically
|
gptkbp:usedBy |
pharmacists
pharmaceutical industry healthcare professionals regulatory authorities quality control laboratories |
gptkbp:website |
https://www.edqm.eu/en/european-pharmacopoeia-ph-eur-9th-edition
|
gptkbp:bfsParent |
gptkb:Japanese_Pharmacopoeia
gptkb:Limulus_Amebocyte_Lysate_(LAL)_assay |
gptkbp:bfsLayer |
6
|